United States of America
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.38 (0.29 - 0.49) | 1994 | Survey/reported | Wasley A et al, 2010 |
0.27 (0.20 - 0.35) | 2006 | Survey/reported | Wasley A et al, 2010 |
0.3 (0.20 - 0.40) | 2012 | Survey/reported | Roberts H et al, 2016 |
0.23 (0.18 - 0.28) | 2015 | Modelled | WHO |
0.3 (0.20 - 0.30) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
0.27 (0.24 - 0.30) | 2013 | Modelled | Schweitzer et al, 2015 |
0.34 (0.30 - 0.38) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
0.37 (0.32 - 0.42) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.37 (0.33 - 0.42) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.38 (0.34 - 0.43) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.4 (0.35 - 0.44) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.4 (0.35 - 0.45) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.41 (0.36 - 0.46) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.42 (0.37 - 0.47) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.43 (0.38 - 0.48) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.44 (0.39 - 0.49) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.44 (0.39 - 0.50) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.46 (0.40 - 0.51) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.47 (0.41 - 0.53) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.48 (0.42 - 0.54) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.49 (0.43 - 0.55) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.49 (0.43 - 0.56) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.5 (0.44 - 0.56) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.51 (0.44 - 0.57) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.51 (0.45 - 0.57) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.51 (0.45 - 0.58) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.52 (0.45 - 0.58) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.53 (0.46 - 0.59) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.54 (0.47 - 0.60) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.55 (0.47 - 0.61) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.55 (0.48 - 0.62) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.55 (0.48 - 0.62) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.55 (0.48 - 0.63) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.56 (0.48 - 0.63) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.56 (0.49 - 0.64) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.57 (0.49 - 0.64) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.37 (0.32 - 0.41) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.04 (0.03 - 0.05) | 2015 | Modelled | WHO |
0.03 (0.02 - 0.04) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
0.05 (0.03 - 0.06) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.06) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.06) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.06) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.06) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.07) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.07) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.07) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.07) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.05 (0.04 - 0.07) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.07) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.08) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.04 - 0.08) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.06 (0.05 - 0.08) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.07 (0.05 - 0.09) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.07 (0.05 - 0.09) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.07 (0.06 - 0.10) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.08 (0.06 - 0.11) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.09 (0.07 - 0.12) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.11 (0.08 - 0.14) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.13 (0.10 - 0.17) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.16 (0.12 - 0.20) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.19 (0.14 - 0.24) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.01 (0.01 - 0.02) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
875,000 (654,000 - 1,033,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
862,000 | 2016 | Survey/reported | Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR |
2,400,000 | 2016 | Survey/reported | Wong, R.J. et al |
1,108,930 (968,729 - 1,253,410) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
1,139,350 (995,333 - 1,285,450) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,138,660 (996,177 - 1,285,030) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,140,310 (997,996 - 1,283,890) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,172,620 (1,028,550 - 1,312,930) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,203,950 (1,054,600 - 1,344,410) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,210,520 (1,062,790 - 1,352,820) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,226,200 (1,079,990 - 1,370,680) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,244,380 (1,098,100 - 1,392,220) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,258,920 (1,109,190 - 1,409,830) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,264,050 (1,115,330 - 1,417,690) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,273,340 (1,122,470 - 1,428,880) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,297,110 (1,141,020 - 1,456,370) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,324,450 (1,161,580 - 1,485,660) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,345,230 (1,176,000 - 1,511,760) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,350,000 (1,178,460 - 1,518,630) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,347,300 (1,177,160 - 1,513,260) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,349,680 (1,179,240 - 1,513,010) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,353,220 (1,184,700 - 1,516,250) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,354,100 (1,184,790 - 1,516,640) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,348,870 (1,181,620 - 1,516,390) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,347,200 (1,179,820 - 1,512,460) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,356,070 (1,183,340 - 1,523,440) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,367,970 (1,193,370 - 1,534,730) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,375,870 (1,198,600 - 1,544,970) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,373,270 (1,193,270 - 1,544,810) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,365,560 (1,187,140 - 1,536,170) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,361,670 (1,182,960 - 1,536,740) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,360,050 (1,181,530 - 1,541,050) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,359,260 (1,179,500 - 1,545,610) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1,358,120 (1,178,630 - 1,545,100) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Number of new cases of HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
20,700 (11,800 - 50,800) | 2019 | Survey/reported | US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B |
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
0.5 | 2014 | Survey/reported | US CDC |
0.45 | 2016 | Survey/reported | US CDC |
0.46 | 2017 | Survey/reported | US CDC |
0.52 | 2010 | Survey/reported | US CDC |
0.51 | 2011 | Survey/reported | US CDC |
0.51 | 2012 | Survey/reported | US CDC |
0.53 | 2013 | Survey/reported | US CDC |
0.46 | 2015 | Survey/reported | US CDC |
0.42 | 2019 | Survey/reported | US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B |
1.37 (1.18 - 1.58) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
0.98 (0.88 - 1.10) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.97 (0.87 - 1.06) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.96 (0.86 - 1.05) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.97 (0.88 - 1.06) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.99 (0.90 - 1.07) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
0.97 (0.89 - 1.06) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1 (0.91 - 1.08) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.01 (0.92 - 1.10) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.03 (0.95 - 1.12) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.06 (0.97 - 1.15) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.08 (0.99 - 1.18) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.12 (1.02 - 1.22) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.1 (1.01 - 1.20) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.13 (1.03 - 1.23) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.13 (1.03 - 1.23) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.16 (1.06 - 1.26) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.18 (1.08 - 1.28) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (1.08 - 1.29) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.2 (1.10 - 1.32) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.22 (1.11 - 1.34) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.24 (1.12 - 1.36) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.27 (1.15 - 1.40) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.31 (1.18 - 1.45) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.35 (1.22 - 1.50) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.39 (1.25 - 1.54) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.4 (1.25 - 1.57) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.34 (1.17 - 1.52) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.43 (1.28 - 1.59) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.36 (1.18 - 1.55) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.37 (1.18 - 1.58) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
11,522 | 2016 | Modelled | WHO |
1,662 | 2019 | Survey/reported | US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B |
2,498 (2,240 - 2,778) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,475 (2,228 - 2,727) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,479 (2,241 - 2,724) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,576 (2,351 - 2,803) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,639 (2,413 - 2,869) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,533 (2,299 - 2,770) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,688 (2,461 - 2,917) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,752 (2,520 - 2,989) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,845 (2,611 - 3,087) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,947 (2,705 - 3,193) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,041 (2,791 - 3,302) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,196 (2,930 - 3,479) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,120 (2,858 - 3,393) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,262 (2,985 - 3,558) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,292 (3,017 - 3,587) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,408 (3,118 - 3,714) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,498 (3,202 - 3,815) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,569 (3,252 - 3,893) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,739 (3,397 - 4,099) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,654 (3,327 - 4,001) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,965 (3,595 - 4,371) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,817 (3,459 - 4,201) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,108 (3,718 - 4,542) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,261 (3,856 - 4,728) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,516 (4,023 - 5,073) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,584 (4,107 - 5,100) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,423 (3,984 - 4,917) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,345 (3,813 - 4,935) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,422 (3,862 - 5,064) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,486 (3,874 - 5,178) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
4,486 (3,874 - 5,178) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of HepB birth dose
Newborns
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
67 | 2019 | Survey/reported | WHO/UNICEF |
66 | 2018 | Survey/reported | WHO/UNICEF |
64 | 2017 | Survey/reported | WHO/UNICEF |
64 | 2016 | Survey/reported | WHO/UNICEF |
72 | 2015 | Survey/reported | WHO/UNICEF |
72 | 2014 | Survey/reported | WHO/UNICEF |
74 | 2013 | Survey/reported | WHO/UNICEF |
72 | 2012 | Survey/reported | WHO/UNICEF |
69 | 2011 | Survey/reported | WHO/UNICEF |
64 | 2010 | Survey/reported | WHO/UNICEF |
61 | 2009 | Survey/reported | WHO/UNICEF |
55 | 2008 | Survey/reported | WHO/UNICEF |
53 | 2007 | Survey/reported | WHO/UNICEF |
50 | 2006 | Survey/reported | WHO/UNICEF |
50 | 2005 | Survey/reported | WHO/UNICEF |
48 | 2004 | Survey/reported | WHO/UNICEF |
39 | 2003 | Survey/reported | WHO/UNICEF |
21 | 2002 | Survey/reported | WHO/UNICEF |
69 | 2020 | Survey/reported | WHO/UNICEF |
76 | 2017 | Survey/reported | Hill HA et al, 2020 |
69 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
91 | 2019 | Survey/reported | WHO/UNICEF |
91 | 2020 | Survey/reported | WHO/UNICEF |
91 | 2017 | Survey/reported | Hill HA et al, 2020 |
91 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Proportion of persons living with HBV diagnosed
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
32 | 2016 | Survey/reported | U.S. Department of Health and Human Services |
Proportion of diagnosed HBV persons receiving appropriate treatment
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
30 (11 - 49) | 2016 | Survey/reported | NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013 |
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
National prevalence survey within the last 5 years
Adopted
Estimates of economic burden
Adopted
System for monitoring testing and treatment
Partially Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
1999
Recommendations for HBV testing of pregnant women
Adopted
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Not Adopted
HBV testing policy
Pregnant women, Risk-based
HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)
Adopted
No patient co-pays for HBsAg testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: No treatment co-pays
Partially Adopted
Adult HBV vaccination policy for high-risk populations
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
National prevalence survey within the last 5 years
Adopted
Estimates of economic burden
Adopted
System for monitoring testing and treatment
Partially Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Eligible for HCV generic medicines
Licensed point-of-care PCR testing to detect HCV
Not Adopted
HCV testing policy
Universal
No patient co-pays for anti-HCV testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Partially Adopted
Simplified care: No treatment co-pays
Partially Adopted
No fibrosis restrictions
Partially Adopted
No sobriety restrictions
Partially Adopted
National policy for harm reduction for persons who inject drugs
Adopted
National policy for syringe exchange in federal prisons
Not Adopted
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Decriminalization of possession of syringes and paraphernalia
Partially Adopted
Public budget line for testing and treatment
Adopted
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1 (0.80 - 1.10) | 2016 | Survey/reported | Hofmeister MG et al, 2019 (Adjusted) |
1 (0.80 - 1.20) | 2010 | Survey/reported | Denniston MM et al, 2014 (Unadjusted) |
1.3 (1 - 1.50) | 2002 | Survey/reported | Armstrong GL wt al, 2006 (Unadjusted) |
0.9 (0.70 - 1.20) | 2015 | Modelled | Blach et al, 2017 |
0.84 (0.75 - 0.96) | 2016 | Survey/reported | Rosenberg et al, 2018 (Unadjusted) |
0.93 | 2016 | Survey/reported | Rosenberg et al, 2018 (Adjusted) |
1 (0.90 - 1.80) | 2014 | Modelled | Gower et al, 2014 |
1.25 (1.02 - 1.54) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.26 (1.02 - 1.55) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.26 (1.02 - 1.54) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.23 (1 - 1.51) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.2 (0.98 - 1.47) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.97 - 1.46) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.97 - 1.46) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.97 - 1.46) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.96 - 1.46) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.96 - 1.46) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.96 - 1.47) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.2 (0.97 - 1.48) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.22 (0.98 - 1.50) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.23 (0.99 - 1.52) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.24 (1 - 1.53) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.24 (1 - 1.53) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.24 (0.99 - 1.53) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.24 (0.99 - 1.53) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.23 (0.99 - 1.53) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.23 (0.98 - 1.52) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.21 (0.97 - 1.50) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.19 (0.95 - 1.47) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.16 (0.93 - 1.44) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.13 (0.91 - 1.41) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.12 (0.90 - 1.39) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.1 (0.88 - 1.37) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.09 (0.87 - 1.36) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.08 (0.87 - 1.34) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.06 (0.85 - 1.32) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.05 (0.84 - 1.31) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
1.18 (0.95 - 1.45) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.49 (0.37 - 0.64) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.7 (1.40 - 2) | 2016 | Survey/reported | Hofmeister MG et al, 2019 (Adjusted) |
1.3 (1.20 - 1.50) | 2010 | Survey/reported | Denniston MM et al, 2014 (Unadjusted) |
1.6 (1.30 - 1.90) | 2002 | Survey/reported | Armstrong GL wt al, 2006 (Unadjusted) |
1.8 (1.50 - 2.30) | 1994 | Survey/reported | Alter MJ et al, 1999 (Unadjusted) |
1.9 (1.50 - 2.50) | 2002 | Survey/reported | Ditah et al, 2014 |
1.3 (0.90 - 1.80) | 2006 | Survey/reported | Ditah et al, 2014 |
1.48 | 2019 | Modelled | Jin et al. 2017 |
1.3 (1.20 - 2.40) | 2014 | Modelled | Gower et al, 2014 |
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
9.7 (7.10 - 12.60) | 2019 | Modelled | Jin et al. 2017 |
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
53.1 (38.10 - 68) | 2016 | Modelled | Degenhardt L et al, 2017 |
Men who have sex with men (MSM)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
4.4 | 2019 | Modelled | Jin et al. 2017 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
2,936,000 (2,231,000 - 3,826,000) | 2015 | Modelled | Blach et al, 2017 |
2,400,000 | 2016 | Survey/reported | US CDC |
2,519,250 (2,019,580 - 3,149,250) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,567,040 (2,059,080 - 3,206,460) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,620,180 (2,107,400 - 3,268,480) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,676,400 (2,154,060 - 3,340,820) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,732,710 (2,198,420 - 3,399,680) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,789,860 (2,248,100 - 3,464,760) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,860,910 (2,305,140 - 3,551,960) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
2,954,980 (2,380,770 - 3,673,490) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,056,730 (2,463,570 - 3,801,140) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,148,740 (2,535,630 - 3,911,860) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,216,480 (2,589,140 - 3,993,100) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,261,100 (2,626,960 - 4,034,700) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,300,340 (2,660,860 - 4,078,900) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,335,740 (2,690,850 - 4,127,690) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,367,660 (2,721,080 - 4,172,570) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,398,480 (2,749,450 - 4,216,270) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,414,710 (2,765,800 - 4,236,680) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,414,940 (2,768,060 - 4,229,390) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,410,470 (2,766,150 - 4,215,210) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,411,690 (2,770,420 - 4,208,510) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,432,700 (2,793,440 - 4,225,520) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,466,620 (2,819,040 - 4,264,040) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,502,940 (2,851,980 - 4,303,690) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,542,590 (2,884,740 - 4,345,020) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,585,500 (2,921,770 - 4,393,670) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,634,680 (2,947,680 - 4,451,870) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,749,680 (3,048,880 - 4,594,180) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,864,380 (3,141,540 - 4,732,270) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,899,850 (3,171,200 - 4,776,430) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,900,550 (3,170,570 - 4,781,980) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
3,865,100 (3,131,620 - 4,746,640) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
DownloadValue | Year | Type | Source |
---|---|---|---|
368,000 (280,000 - 480,000) | 2019 | Modelled | Dugan et al., 2021 |
Number of new cases of HCV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
57,500 (45,500 - 196,000) | 2019 | Survey/reported | US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C |
Rate of new HCV cases
American Indian/Alaska Native
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
3.6 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
3.6 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
2.9 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
3.1 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
1.7 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
1.3 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
1.7 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
2 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
1.08 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.5 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.46 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
0.5 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
Showing out of
Show more
Asian/Pacific Islander
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.2 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
0.2 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
0.1 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
0.1 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.1 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.1 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.1 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.1 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.05 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.04 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
0.04 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
Showing out of
Show more
Black, non-Hispanic
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.7 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
0.6 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
0.5 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
0.3 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.3 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.2 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.2 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.2 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.14 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.12 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.1 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
0.2 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
Showing out of
Show more
Hispanic
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.6 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
0.5 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
0.4 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
0.4 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.3 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.2 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.2 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.2 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.17 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.16 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.1 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
0.1 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
Showing out of
Show more
White, non-Hispanic
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
1.4 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
1.3 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
1.2 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
1.1 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.9 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.8 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.8 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.6 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.47 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.32 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.3 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
0.3 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
Showing out of
Show more
0-19 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.1 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
0.1 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
0.1 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
0.1 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.1 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.1 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.1 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.11 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.1 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
Showing out of
Show more
Less than 15 years old
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
20-29 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
2.9 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
3.1 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
2.8 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
2.7 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
2.4 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
2.2 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
2 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
1.73 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
1.18 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.8 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.7 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
Showing out of
Show more
25-39 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.5 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
30-39 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
3.2 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
2.6 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
2.3 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
2.2 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
1.7 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
1.7 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
1.3 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
1.1 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.8 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.6 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.5 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
Showing out of
Show more
15-24 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.4 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
50-59 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
1.1 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
0.9 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
0.8 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
0.6 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.6 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.4 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.5 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.4 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.3 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.3 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.3 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
Showing out of
Show more
40-49 year olds
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
1.7 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
1.3 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
1.1 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
1.2 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.9 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.7 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.7 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.6 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.5 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0.4 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.5 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
Showing out of
Show more
Over 40 years old
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.3 | 2008 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2008 |
Over 60 years old
DownloadValue (Number of new cases per 100,000 persons) | Year | Type | Source |
---|---|---|---|
0.5 | 2019 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2019 |
0.4 | 2018 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2018 |
0.3 | 2017 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2017 |
0.2 | 2016 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.1 | 2015 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2016 |
0.1 | 2014 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2014 |
0.1 | 2013 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2013 |
0.1 | 2012 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2012 |
0.07 | 2011 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2011 |
0 | 2010 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2010 |
0.04 | 2009 | Survey/reported | US CDC. Viral Hepatitis Surveillance Report 2009 |
Showing out of
Show more
HCV-related death rate
National
DownloadValue (Deaths per 100,000) | Year | Type | Source |
---|---|---|---|
4.45 | 2016 | Survey/reported | US CDC, 2016 |
4.91 | 2015 | Survey/reported | US CDC, 2020 |
5.01 | 2014 | Survey/reported | US CDC, 2019 |
5.03 | 2013 | Survey/reported | US CDC, 2018 |
4.96 | 2012 | Survey/reported | US CDC, 2017 |
3.33 | 2019 | Survey/reported | US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C |
11.9 (10.80 - 13.10) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
6.68 (6.07 - 7.37) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.8 (6.24 - 7.43) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
6.95 (6.41 - 7.53) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.23 (6.70 - 7.80) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.4 (6.87 - 7.95) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.56 (7.03 - 8.13) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.63 (7.10 - 8.20) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.75 (7.23 - 8.33) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
7.94 (7.39 - 8.53) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.17 (7.63 - 8.78) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.4 (7.87 - 9.01) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.84 (8.27 - 9.48) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
8.62 (8.08 - 9.25) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
9 (8.41 - 9.66) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.01 (8.41 - 9.68) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.24 (8.62 - 9.95) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.4 (8.76 - 10.12) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.54 (8.88 - 10.27) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.77 (9.09 - 10.54) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.14 (9.40 - 10.92) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
9.99 (9.28 - 10.78) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.44 (9.69 - 11.24) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.67 (9.88 - 11.51) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
10.89 (10.09 - 11.78) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.14 (10.32 - 12.07) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.4 (10.55 - 12.37) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.73 (10.77 - 12.76) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.72 (10.61 - 12.91) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.85 (10.73 - 13.07) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
11.94 (10.83 - 13.15) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
21,698 | 2016 | Modelled | WHO |
14,242 | 2019 | Survey/reported | US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C |
39,158 (35,520 - 43,124) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
39,158 (35,520 - 43,124) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
38,668 (35,028 - 42,654) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
38,054 (34,421 - 41,900) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
37,842 (34,759 - 41,187) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
36,565 (33,841 - 39,660) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
35,460 (32,872 - 38,434) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
34,425 (31,893 - 37,241) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
33,475 (31,022 - 36,115) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
32,530 (30,185 - 35,022) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
31,333 (29,056 - 33,738) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
30,611 (28,418 - 33,016) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
29,671 (27,590 - 31,990) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
28,701 (26,694 - 30,881) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
27,985 (26,076 - 30,138) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
27,242 (25,403 - 29,330) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
26,287 (24,541 - 28,240) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
26,004 (24,309 - 27,918) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
25,293 (23,674 - 27,122) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
24,439 (22,913 - 26,212) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
23,578 (22,096 - 25,300) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
22,700 (21,193 - 24,409) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
21,850 (20,334 - 23,461) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
21,121 (19,696 - 22,687) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
20,584 (19,155 - 22,118) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
20,201 (18,781 - 21,711) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
19,577 (18,175 - 21,045) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
18,940 (17,555 - 20,435) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
18,010 (16,624 - 19,510) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
17,433 (16,011 - 19,047) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
16,950 (15,387 - 18,693) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of persons initiating HCV treatment
National
DownloadValue | Year | Type | Source |
---|---|---|---|
109,096 | 2014 | Survey/reported | Teshale et al, 2022 |
164,232 | 2015 | Survey/reported | Teshale et al, 2022 |
134,285 | 2016 | Survey/reported | Teshale et al, 2022 |
114,419 | 2017 | Survey/reported | Teshale et al, 2022 |
122,664 | 2018 | Survey/reported | Teshale et al, 2022 |
114,893 | 2019 | Survey/reported | Teshale et al, 2022 |
83,740 | 2020 | Survey/reported | Teshale et al, 2022 |
Showing out of
Show more
Demographic breakdown of persons treated for HCV
Females (2014-2020)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
39.2 | 2020 | Survey/reported | Teshale et al, 2022 |
Persons born after 1965
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
17.4 | 2014 | Survey/reported | Teshale et al, 2022 |
51.3 | 2020 | Survey/reported | Teshale et al, 2022 |
Showing out of
Show more
Persons born during 1945–1965
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
73.6 | 2014 | Survey/reported | Teshale et al, 2022 |
46.3 | 2020 | Survey/reported | Teshale et al, 2022 |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
DownloadValue | Year | Type | Source |
---|---|---|---|
30 (11 - 49) | 2016 | Survey/reported | NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013 |
Proportion of persons living with HCV diagnosed
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
60 | 2016 | Survey/reported | U.S. Department of Health and Human Services |
Proportion of persons living with HCV who have cleared HCV infection
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
43 | 2016 | Survey/reported | U.S. Department of Health and Human Services |
HBV National Action Plan
HBV elimination goal
Year of HBV elimination goal
2030
National prevalence survey within the last 5 years
Adopted
Estimates of economic burden
Adopted
System for monitoring testing and treatment
Partially Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
1999
Recommendations for HBV testing of pregnant women
Adopted
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Not Adopted
HBV testing policy
Pregnant women, Risk-based
HBV testing recommendations for key population (i.e. migrants, foreign-born, etc)
Adopted
No patient co-pays for HBsAg testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: No treatment co-pays
Partially Adopted
Adult HBV vaccination policy for high-risk populations
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
Year of HCV elimination goal
2030
National prevalence survey within the last 5 years
Adopted
Estimates of economic burden
Adopted
System for monitoring testing and treatment
Partially Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Eligible for HCV generic medicines
Licensed point-of-care PCR testing to detect HCV
Not Adopted
HCV testing policy
Universal
No patient co-pays for anti-HCV testing
Adopted
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Partially Adopted
Simplified care: No treatment co-pays
Partially Adopted
No fibrosis restrictions
Partially Adopted
No sobriety restrictions
Partially Adopted
National policy for harm reduction for persons who inject drugs
Adopted
National policy for syringe exchange in federal prisons
Not Adopted
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Decriminalization of possession of syringes and paraphernalia
Partially Adopted
Public budget line for testing and treatment
Adopted
Overview
HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Modelled
HBV
4,486
2019
(3,874 - 5,178)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
HBV
1,662
2019
US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis B
HBV chart
Modelled
HCV
39,158
2019
(35,520 - 43,124)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
HCV
14,242
2019
US CDC: Viral Hepatitis Surveillance Report 2019 - Hepatitis C
HCV chart
Prevalence < 5
HBV
0.01
(%)
2020, latest modelled
(0.01 - 0.02(%))
WHO
No. of syringes/PWID/year
Survey/surveillance
HCV
30
2016
(11 - 49)
NASEN, 2015; Wejnert C et al, 2016; Des Jarlais D et al , 2013
Eligible for HBV generic medicines
Eligible for HCV generic medicines